X-120379539-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001142447.3(ATP1B4):āc.979G>Cā(p.Val327Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000414 in 1,209,142 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes š: 0.0000036 ( 0 hom. 2 hem. )
Consequence
ATP1B4
NM_001142447.3 missense
NM_001142447.3 missense
Scores
1
3
13
Clinical Significance
Conservation
PhyloP100: 3.83
Genes affected
ATP1B4 (HGNC:808): (ATPase Na+/K+ transporting family member beta 4) This gene has been found in all vertebrate genomes sequenced to date. However, this gene has undergone a change in function in placental mammals compared to other species. Specifically, in fish, avian, and amphibian species, this gene encodes plasma membrane-bound beta-subunits of Na,K-ATPase. In placental mammals, the encoded protein interacts with the nuclear transcriptional coregulator SKIP and may be involved in the regulation of TGF-beta signaling. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.24462926).
BS2
High Hemizygotes in GnomAdExome4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP1B4 | NM_001142447.3 | c.979G>C | p.Val327Leu | missense_variant | 8/8 | ENST00000218008.8 | NP_001135919.1 | |
ATP1B4 | NM_012069.5 | c.967G>C | p.Val323Leu | missense_variant | 8/8 | NP_036201.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP1B4 | ENST00000218008.8 | c.979G>C | p.Val327Leu | missense_variant | 8/8 | 1 | NM_001142447.3 | ENSP00000218008 | P1 | |
ATP1B4 | ENST00000361319.3 | c.967G>C | p.Val323Leu | missense_variant | 8/8 | 1 | ENSP00000355346 | |||
ATP1B4 | ENST00000539306.5 | c.850G>C | p.Val284Leu | missense_variant | 7/7 | 2 | ENSP00000443334 |
Frequencies
GnomAD3 genomes AF: 0.00000892 AC: 1AN: 112057Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34213
GnomAD3 genomes
AF:
AC:
1
AN:
112057
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34213
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000275 AC: 5AN: 181942Hom.: 0 AF XY: 0.0000301 AC XY: 2AN XY: 66534
GnomAD3 exomes
AF:
AC:
5
AN:
181942
Hom.:
AF XY:
AC XY:
2
AN XY:
66534
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000365 AC: 4AN: 1097085Hom.: 0 Cov.: 29 AF XY: 0.00000552 AC XY: 2AN XY: 362469
GnomAD4 exome
AF:
AC:
4
AN:
1097085
Hom.:
Cov.:
29
AF XY:
AC XY:
2
AN XY:
362469
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000892 AC: 1AN: 112057Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34213
GnomAD4 genome
AF:
AC:
1
AN:
112057
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34213
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 07, 2023 | The c.979G>C (p.V327L) alteration is located in exon 8 (coding exon 8) of the ATP1B4 gene. This alteration results from a G to C substitution at nucleotide position 979, causing the valine (V) at amino acid position 327 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.
MutationTaster
Benign
D;D;D
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;D;T
Sift4G
Benign
T;T;T
Polyphen
B;B;B
Vest4
MutPred
0.66
.;Loss of catalytic residue at V327 (P = 0.0572);.;
MVP
MPC
0.31
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at